Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADH1A | P07327 | 1/20 | 0.43 |
| ▸ | KIT | P10721 | 1/20 | 0.43 |
| ▸ | FLT1 | P17948 | 1/20 | 0.43 |
| ▸ | FLT4 | P35916 | 1/20 | 0.43 |
| ▸ | KDR | P35968 | 1/20 | 0.43 |
| ▸ | ABL2 | P42684 | 1/20 | 0.43 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.38 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.38 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.38 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.38 |
| ▸ | TLR9 | Q9NR96 | 1/20 | 0.38 |
| ▸ | TLR7 | Q9NYK1 | 1/20 | 0.38 |
| ▸ | DTYMK | P23919 | 2/20 | 0.36 |
| ▸ | CNR2 | P34972 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 2/20 | 0.35 |
| ▸ | THRB | P10828 | 1/20 | 0.35 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10066358 | 1.00 | ADH1A (0.43) | ADH1AKITFLT1FLT4KDR | |
| SCHEMBL16486910 | 1.00 | ADH1A (0.43) | ADH1AKITFLT1FLT4KDR | |
| SCHEMBL13007043 | 0.92 | CHRM2 (0.40) | CHRM2CHRM4CHRM1CHRM3TLR9 | |
| SCHEMBL20297102 | 0.89 | ADH1A (0.46) | ADH1AKITFLT1FLT4KDR | |
| SCHEMBL21961762 | 0.87 | ADH1A (0.41) | ADH1AKITFLT1KDRABL2 | |
| SCHEMBL16933036 | 0.87 | ADH1A (0.47) | ADH1AKITFLT1FLT4KDR | |
| SCHEMBL13007044 | 0.87 | ADH1A (0.47) | ADH1AKITFLT1FLT4KDR | |
| SCHEMBL31036684 | 0.85 | ADH1A (0.39) | ADH1AKITFLT1FLT4KDR | |
| SCHEMBL12596982 | 0.85 | ADH1A (0.49) | ADH1AKITFLT1FLT4KDR | |
| SCHEMBL12596985 | 0.85 | ADH1A (0.49) | ADH1AKITFLT1FLT4KDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200289659-A1 | CONJUGATES FOR TREATING DISEASES | ENDOCYTE INC (US) | 2020-09-17 | — | — | US | disclosed |
| WO-2016148674-A1 | CONJUGATES FOR TREATING DISEASES | ENDOCYTE, INC. (US) | 2016-09-22 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200289659-A1 | CONJUGATES FOR TREATING DISEASES | CD79B, MALT1, TPMT | ADH1A 445/4885KIT 2248/4885FLT1 3245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.